Cargando…
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.”
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888857/ https://www.ncbi.nlm.nih.gov/pubmed/31527688 http://dx.doi.org/10.1038/s41416-019-0577-4 |
_version_ | 1783475319029628928 |
---|---|
author | Munzone, Elisabetta Pagan, Eleonora Bagnardi, Vincenzo Mazzocco, Ketti |
author_facet | Munzone, Elisabetta Pagan, Eleonora Bagnardi, Vincenzo Mazzocco, Ketti |
author_sort | Munzone, Elisabetta |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6888857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68888572020-09-17 Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” Munzone, Elisabetta Pagan, Eleonora Bagnardi, Vincenzo Mazzocco, Ketti Br J Cancer Correspondence Nature Publishing Group UK 2019-09-17 2019-10-29 /pmc/articles/PMC6888857/ /pubmed/31527688 http://dx.doi.org/10.1038/s41416-019-0577-4 Text en © Cancer Research UK 2019 https://creativecommons.org/licenses/by/4.0/Note: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
spellingShingle | Correspondence Munzone, Elisabetta Pagan, Eleonora Bagnardi, Vincenzo Mazzocco, Ketti Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title | Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title_full | Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title_fullStr | Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title_full_unstemmed | Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title_short | Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
title_sort | reply to comments on: “preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888857/ https://www.ncbi.nlm.nih.gov/pubmed/31527688 http://dx.doi.org/10.1038/s41416-019-0577-4 |
work_keys_str_mv | AT munzoneelisabetta replytocommentsonpreventingchemotherapyinducedalopeciaaprospectiveclinicaltrialontheefficacyandsafetyofascalpcoolingsysteminearlybreastcancerpatientstreatedwithanthracyclines AT paganeleonora replytocommentsonpreventingchemotherapyinducedalopeciaaprospectiveclinicaltrialontheefficacyandsafetyofascalpcoolingsysteminearlybreastcancerpatientstreatedwithanthracyclines AT bagnardivincenzo replytocommentsonpreventingchemotherapyinducedalopeciaaprospectiveclinicaltrialontheefficacyandsafetyofascalpcoolingsysteminearlybreastcancerpatientstreatedwithanthracyclines AT mazzoccoketti replytocommentsonpreventingchemotherapyinducedalopeciaaprospectiveclinicaltrialontheefficacyandsafetyofascalpcoolingsysteminearlybreastcancerpatientstreatedwithanthracyclines |